Physician profile
Lisa Van
NPI 1689170664
$1,642.49
in general payments reported to CMS, 2019-2025
17 companies · $836 in 2025
The $836 reported for 2025 was more than what 88% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $155 · 2021: $224 · 2022: $272 · 2023: $119 · 2024: $37.36 · 2025: $836.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $992.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $992.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $286.82 | 2022-2025 | Tyrvaya |
| Alcon Vision LLC | $249.24 | 2021-2025 | Rocklatan, Tryptyr, Simbrinza |
| Sun Pharmaceutical Industries INC. | $239.08 | 2020-2025 | |
| Bausch & Lomb Americas INC. | $232.03 | 2023-2025 | Miebo, Lotemax Sm, Prolensa |
| Aerie Pharmaceuticals, INC. | $105.76 | 2020-2021 | |
| Glaukos Corporation | $103.68 | 2025 | Idosetr |
| Abbvie INC. | $94.17 | 2022-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $60.12 | 2020-2021 | |
| Genentech USA, INC. | $50.95 | 2022 | |
| Optos, INC. | $42.96 | 2020-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $42.76 | 2021 | |
| Dompe US, INC. | $32.96 | 2023 | Oxervate |
| Rayner Intraocular Lenses Limited | $25.10 | 2025 | Omidria |
| Eyevance Pharmaceuticals LLC | $23.55 | 2020 | |
| Thea Pharma INC. | $21.77 | 2025 | Iyuzeh |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $17.90 | 2021 | |
| Coopervision INC. | $13.64 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Van listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.